Therefore, we investigated the effects of pitavastatin on serum adiponectin, including HMW adiponectin and insulin resistance, according to a homeostatic model for insulin resistance (HOMA-IR) and a homeostasis model of beta cell function (HOMA-β), in patients with type 2 DM and dyslipidemia. Here, ADIPOQ is linked to metabolic syndrome.